FDA advisory panel recommends Pfizer booster shots for people 65 and older

On Friday, an advisory panel to the Food and Drug Administration voted in favor of recommending COVID-19 booster shots for people 65 and older and individuals with risk of severe illness from the coronavirus who have already received their first two shots of the Pfizer-BioNTech vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting